The "minimal initial benefit" group (approximately 5-10% of users) reported limited improvements during treatment making discontinuation effects irrelevant, typically explained by inadequate product quality with degraded or low-concentration GHK-Cu, inappropriate application technique reducing absorption, unrealistic expectations exceeding what any topical can achieve, severe underlying pathology requiring medical intervention beyond cosmetic peptides, or individual non-responsiveness to copper peptide treatment for genetic or physiological reasons
Alliance 3 , e201900565 (2020)
Preparing for the appointment Before your client gets their freckles, theyll need to follow a few standard permanent makeup rules
July/August 2025
Whats arguably the most important factor that determines whether AOD 9604 works for you is not your dosage or the peptides brand, but whether its prescribed and supervised by a licensed clinician using a compounded, lab-verified product
These stimulate the release of GLP-1 [1,3,4]